Evaluation of a New Biocompatible Pressure Equalizing Tube

Sponsor
University of California, Irvine (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01775709
Collaborator
Beckman Laser Institute University of California Irvine (Other)
0
1
1
26
0

Study Details

Study Description

Brief Summary

Otitis media is the most common illness in children and 5% to 10% of their symptom cause by fluids in their middle ear . The OME can cause hearing loss included poor development of speech and poor communication.

The surgical procedure is considered simple and relatively safe, but several complications may occur after Pressure Equalizing tube insertion. The most prevalent complications are otorrhea, biofilm and formation of retraction pockets. Otorrhea occurs in 30% to 83% of children with tube and is mainly due bacterial contamination of the middle ear either from external ear canal or impaired Eustachian tube. Swimming can facilitate the entry of bacteria into the middle ear from the ear canal through the PE tubes, and this assumption is reinforced by the statistically significant association between the rate of otorrhea and the non-utilization of ear plugs in children who swim (from 47% in children who used ear plugs to 56% in those who did not).

Condition or Disease Intervention/Treatment Phase
  • Device: PE tube with Duckbill Valve
N/A

Detailed Description

The researcher at Beckman Laser Institute, University of California, Irvine, develops new medical tool device call biocompatible Pressure Equalizing tube which can stop air passage and pressure equalization instantly, and can prevents water into the middle ear cavity. evaluate and compare the efficacy of a biocompatible Pressure Equalizing tube that enables air passage and pressure equalization almost instantly, while prevents the entrance of fluids, specially water, into the middle ear cavity.

The biocompatible Pressure Equalizing tube can reduce the rate of postoperative otorrhea,air passage between outside and middle ear cavity,prevents formation of retraction pockets in TM and swimming with lower risk of otorrhea.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Evaluation of a New Biocompatible Pressure Equalizing Tube
Study Start Date :
Jul 1, 2012
Actual Primary Completion Date :
Sep 1, 2014
Actual Study Completion Date :
Sep 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: PE tube with Duckbill Valve

PE tube with Duckbill Valve

Device: PE tube with Duckbill Valve
PE tube with Duckbill Valve

Outcome Measures

Primary Outcome Measures

  1. Pressure-equalizing tube with Duckbill Valve stop air and water passage during middle ear infection treatment [up to 6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Male/ female at all age- newborn to adult.

  2. Non- pregnant woman.

  3. Diagnose of middle ear infection and plan for surgery procedure

Exclusion Criteria:
  1. Pregnant woman

  2. Incompetent adults (i.e. individuals with cognitive impairment)

  3. Presence of immunodeficiency; cystic fibrosis; sickle cell disease;

  4. Another major systemic disease

  5. Congenital malformation of the external, middle, or inner ear

  6. Sensorineural hearing loss; otoneurologic disease

  7. History of prior ear surgery such as tympanoplasty, tympanomastoidectomy, or mastoidectomy; cholesteatoma; chronic mastoiditis; intratemporal or intracranial suppurative complications of otitis media

  8. Use of ototoxic medication (except topical use)

Contacts and Locations

Locations

Site City State Country Postal Code
1 UCIMC Orange California United States 92868

Sponsors and Collaborators

  • University of California, Irvine
  • Beckman Laser Institute University of California Irvine

Investigators

  • Principal Investigator: Elliot Botvinick, Ph.D., Beckman Laser Institute, UCI

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Beckman Laser Institute and Medical Center, Hamid Djalilian, M.D.,Associate Professor of Clinical Otolaryngology, University of California, Irvine
ClinicalTrials.gov Identifier:
NCT01775709
Other Study ID Numbers:
  • NIH/LAMMP-2012-8774
First Posted:
Jan 25, 2013
Last Update Posted:
Feb 10, 2017
Last Verified:
Feb 1, 2017
Keywords provided by Beckman Laser Institute and Medical Center, Hamid Djalilian, M.D.,Associate Professor of Clinical Otolaryngology, University of California, Irvine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 10, 2017